ShadowBuys
Sign inJoin for free

Rep. Daniel S. Goldman sold Biogen (BIIB)

Rep. Daniel S. Goldman (D-NY-10) · $1K–$15K · traded Mar 6, 2023

Transaction
Sold (partial)
Amount
$1K–$15K
Owner
Not stated
Traded
Mar 6, 2023
Disclosed
Apr 17, 2023
Days to disclose
42
Asset type
Stock
As filed
Biogen Inc.
Industry
Drug Manufacturers - General · Healthcare
Official filing ↗All of Goldman's tradesAll Congress trades in BIIB

Other trades in this filing

All of Goldman's trades →

Recent Congress trades in BIIB

Company context for BIIB

Recent records for the company. These may have been published before or after this trade; compare the dates before drawing a connection.

  1. BIIBFinancial report·SEC EDGAR

    BIIB: 10-Q financial filing

    Filed 10-Q for an event or period dated 2026-09-30. Read the company report for its disclosures.

    Public: Oct 28, 2026, 6:23 AM EDTEvent / period: Sep 30, 2026Original source ↗

    1 congressional household disclosed purchases in the past 90 days. See the trades

  2. BIIBCompany announcement·SEC EDGAR

    BIIB: Financial results

    Filed 8-K for an event or period dated 2026-10-28. Financial results.

    Public: Oct 28, 2026, 6:07 AM EDTEvent / period: Oct 28, 2026Original source ↗

    1 congressional household disclosed purchases in the past 90 days. See the trades

  3. BIIBRegulatory notice·Federal Register

    Granting of Requests for Early Termination of the Waiting Period Under the Premerger Notification Rules

    A Notice notice explicitly mentions the company. Read the cited text for its role.

    Public: Sep 17, 2026Original source ↗

    1 congressional household disclosed purchases in the past 90 days. See the trades

From a periodic transaction report filed under the STOCK Act. Amounts are the ranges members report. Nothing here is investment advice.